Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Genentech licenses rights to Afraxis compounds

Jan. 30, 2013

ElMindA and Purdue Pharma establish research agreement in pain

Jan. 30, 2013

4-Antibody and the Ludwig Institute expand oncology antibody program

Jan. 30, 2013

Phase III APEX study to be expanded into China

Jan. 30, 2013

Algeta begins research program on epratuzumab-based targeted thorium conjugate

Jan. 30, 2013

Companies collaborate on combination studies of simeprevir, TMC-647055 and IDX-719

Jan. 29, 2013

Hanmi Pharmaceutical finds partner to market esomeprazole strontium

Jan. 29, 2013

Baxter to acquire hemophilia compound OBI-1

Jan. 28, 2013

Pharmstandard and Janssen Pharmaceutica collaborate on TB drugs

Jan. 28, 2013

Antitope forms protein deimmunization agreement

Jan. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...